Cargando…
Metformin alleviates breast cancer through targeting high‐mobility group AT‐hook 2
BACKGROUND: As a classic oral drug used in diabetic patients, metformin has exhibited an anticancer role in many types of cancers in recent years. Here, we aimed to investigate the role of metformin in the growth of breast cancer and its novel targets. METHODS: A cell viability assay was utilized to...
Autores principales: | Li, Yang, Wang, Dan, Ren, Hui, Feng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049488/ https://www.ncbi.nlm.nih.gov/pubmed/32031335 http://dx.doi.org/10.1111/1759-7714.13318 |
Ejemplares similares
-
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
por: Ding, Chao, et al.
Publicado: (2022) -
The Dimerization State of the Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2)
por: Frost, Lorraine, et al.
Publicado: (2015) -
High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia
por: Unachukwu, Uchenna, et al.
Publicado: (2020) -
Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma
por: Cui, Juncheng, et al.
Publicado: (2022) -
Modulation of Vascular Smooth Muscle Cell Phenotype by High Mobility Group AT-Hook 1
por: Jung, Yoojin, et al.
Publicado: (2021)